These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24689830)

  • 1. Changes in breast cancer reports after pathology second opinion.
    Marco V; Muntal T; García-Hernandez F; Cortes J; Gonzalez B; Rubio IT
    Breast J; 2014; 20(3):295-301. PubMed ID: 24689830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast pathology review: does it make a difference?
    Romanoff AM; Cohen A; Schmidt H; Weltz CR; Jaffer SM; Nagi CS; Bleiweiss IJ; Port ER
    Ann Surg Oncol; 2014 Oct; 21(11):3504-8. PubMed ID: 24859936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients.
    Khazai L; Middleton LP; Goktepe N; Liu BT; Sahin AA
    J Surg Oncol; 2015 Feb; 111(2):192-7. PubMed ID: 25273328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
    Kósa C; Garami Z; Dinya T; Fülöp B
    Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in breast cancer therapy because of pathology second opinions.
    Staradub VL; Messenger KA; Hao N; Wiley EL; Morrow M
    Ann Surg Oncol; 2002 Dec; 9(10):982-7. PubMed ID: 12464590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandatory second opinion surgical pathology at a large referral hospital.
    Kronz JD; Westra WH; Epstein JI
    Cancer; 1999 Dec; 86(11):2426-35. PubMed ID: 10590387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue.
    Apple SK
    Breast J; 2006; 12(2):145-9. PubMed ID: 16509839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM; Cher-Siangang P; Tan PH
    Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
    Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
    BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.
    Munch-Petersen HD; Rasmussen BB; Balslev E
    APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements.
    Manion E; Cohen MB; Weydert J
    Am J Surg Pathol; 2008 May; 32(5):732-7. PubMed ID: 18360282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.